Buyback, dividend could lift Pfizer stock-Barron’s

NEW YORK, Dec 12 (BestGrowthStock) – A big stock buyback or an
increased dividend could lift Pfizer Inc (PFE.N: ) shares to $25
over the next year, and the retirement of former CEO Jeff
Kindler also gives Pfizer an opportunity to shed assets,
Barron’s said in its Dec 13 edition.

Pfizer, now led by Ian Read, may also reduce its huge $9
billion research-and-development budget, the investment weekly
said.

Pfizer’s higher-value businesses, like animal health and
infant nutritionals, could be valued at around $27 billion if
they were sold or split off, Barron’s said.

Clues to the company’s strategy could come in the next few
days as Pfizer names its board chairman. Investors would cheer
if board member Jim Kilts, who led Nabisco and Gillette, gets
the job, Barron’s said. Investors would be less pleased if
former Pfizer CEO William Steere becomes chairman, according
to the investment weekly.
(Reporting by Nick Zieminski; Editing by Jan Paschal)

Buyback, dividend could lift Pfizer stock-Barron’s